Audit 22031

FY End
2022-06-30
Total Expended
$5.27M
Findings
0
Programs
9
Year: 2022 Accepted: 2023-02-13
Auditor: Leaf & Cole LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.279 Drug Abuse and Addiction Research Programs $677,478 Yes 0
93.113 Environmental Health $500,927 Yes 0
93.310 Trans-Nih Research Support $453,493 Yes 0
93.839 Blood Diseases and Resources Research $301,435 Yes 0
93.859 Biomedical Research and Research Training $144,048 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $118,132 Yes 0
93.172 Human Genome Research $38,333 Yes 0
93.393 Cancer Cause and Prevention Research $25,199 Yes 0
93.855 Allergy, Immunology and Transplantation Research $20,950 Yes 0

Contacts

Name Title Type
ZM3DYHAGMKM3 Christine Auciello Auditee
8582007086 Jill Branch Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.